Who invested in Remix Therapeutics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$60Mraised across 1 round since 2024, from 1 source

Latest round: Venture, $60MJan 2024
Investors: 5

See who backed them

The rounds

Jan 2024
Venture$60M
Source recordedSEC filing: $14M sold, first sale Dec 2023

Founders and team

From the SEC filings it signed: 3 on the team.

Heather WassermanExecutive Officeri
Peter SmithExecutive Officer, Directori
Robert GagnonExecutive Officeri

On the board, as filediJeff GoaterKevin BittermanMatthew PattersonMichael RomeScott Biller

Everyone who backed them

Atlas VentureVC firm1round

ARCH Venture PartnersVC firm1round

Alexandria Venture InvestmentsVC firm1round

Foresite CapitalPrivate equity1round

Casdin CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Remix Therapeutics

Who invested in Remix Therapeutics?

Remix Therapeutics's investors include Atlas Venture, ARCH Venture Partners, Alexandria Venture Investments, Foresite Capital and Casdin Capital.

How much has Remix Therapeutics raised?

Remix Therapeutics has raised $60M across 1 round since 2024.

When did Remix Therapeutics last raise?

Remix Therapeutics's most recent round was a Venture of $60M in Jan 2024.

What was Remix Therapeutics's biggest round?

Its most recent round, $60M in Jan 2024, is also its largest on record.

Who backed Remix Therapeutics first?

Remix Therapeutics's first round on record, in Jan 2024, was backed by Atlas Venture, ARCH Venture Partners and Alexandria Venture Investments and 2 others.